- Home
- OBIO vs XYF Comparison
OBIO vs XYF Comparison
Compare OBIO & XYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OBIO | XYF |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 246.2M | 224.3M |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | OBIO | XYF |
|---|---|---|
| Price | $4.51 | $4.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $14.25 | N/A |
| AVG Volume (30 Days) | 165.7K | ★ 203.4K |
| Earning Date | 05-11-2026 | 05-18-2026 |
| Dividend Yield | N/A | ★ 12.32% |
| EPS Growth | ★ 33.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $33,482,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.43 | N/A |
| P/E Ratio | ★ N/A | $0.90 |
| Revenue Growth | ★ 1169.22 | N/A |
| 52 Week Low | $2.20 | $3.30 |
| 52 Week High | $5.42 | $20.36 |
Technical Indicators
Market Signals| Indicator | OBIO | XYF |
|---|---|---|
| Relative Strength Index (RSI) | 55.74 | 52.10 |
| Support Level | $4.02 | $3.30 |
| Resistance Level | $4.88 | $5.07 |
| Average True Range (ATR) | 0.24 | 0.35 |
| MACD | -0.01 | 0.08 |
| Stochastic Oscillator | 59.49 | 81.94 |
Price Performance
Historical ComparisonAbout OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About XYF X Financial each representing six
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.